Can successful vaccines teach us how to induce efficient protective immune responses? (original) (raw)
Janeway, C.A. Use of concentrated human serum γ-globulin in the prevention and attenuation of measles. Bull. N. Y. Acad. Med.21, 202–222 (1945). CASPubMedPubMed Central Google Scholar
Keller, M.A. & Stiehm, E.R. Passive immunity in prevention and treatment of infectious diseases. Clin. Microbiol. Rev.13, 602–614 (2000). ArticleCASPubMedPubMed Central Google Scholar
Fox, J.P. Modes of action of poliovirus vaccines and relation to resulting immunity. Rev. Infect. Dis.6 (Suppl. 2), S352–S355 (1984). ArticlePubMed Google Scholar
De Quadros, C.A. Polio. in The Vaccine Book (eds. Bloom, B.R. & Lambert, P.H.) 189–196 (Academic Press, Amsterdam, 2003). Chapter Google Scholar
Lampe, R.M., Weir, M.R., Scott, R.M. & Weeks, J.L. Measles reimmunization in children immunized before 1 year of age. Am. J. Dis. Child.139, 33–35 (1985). CASPubMed Google Scholar
Fukuda, K., Levandowski, R.A., Bridges, C.B. & Cox, N.J. Inactivated influenza vaccines. in Vaccines (eds. Plotkin, S.A. & Orenstein, W.A.) 339–370 (Elsevier, Philadelphia, 2004). Google Scholar
Belshe, R., Maassab, H.G. & Mendelman, P.M. Influenza vaccine—live. in Vaccines (eds. Plotkin, S.A. & Orenstein, W.A.) 371–388 (Elsevier, Philadelphia, 2004). Google Scholar
Davies, J.R. & Grilli, E.A. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol. Infect.102, 325–333 (1989). ArticleCASPubMedPubMed Central Google Scholar
Treanor, J.J. et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine18, 899–906 (1999). ArticleCASPubMed Google Scholar
Belshe, R.B. et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis.181, 1133–1137 (2000). ArticleCASPubMed Google Scholar
Manz, R.A., Hauser, A.E., Hiepe, F. & Radbruch, A. Maintenance of serum antibody levels. Annu. Rev. Immunol. (in the press).
McHeyzer-Williams, L.J. & McHeyzer-Williams, M. Antigen-specific memory B cell development. Annu. Rev. Immunol. (in the press).
Gourley, T.S., Wherry, E.J., Masopust, D. & Ahmed, R. Generation and maintenance of immunological memory. Semin. Immunol.16, 323–333 (2004). ArticleCASPubMed Google Scholar
Tokoyoda, K., Egawa, T., Sugiyama, T., Choi, B.I. & Nagasawa, T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity20, 707–718 (2004). ArticleCASPubMed Google Scholar
Ochsenbein, A.F. et al. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. USA97, 13263–13268 (2000). ArticleCASPubMedPubMed Central Google Scholar
Zinkernagel, R.M. On differences between immunity and immunological memory. Curr. Opin. Immunol.14, 523–536 (2002). ArticleCASPubMed Google Scholar
Bernasconi, N.L., Traggiai, E. & Lanzavecchia, A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science298, 2199–2202 (2002). ArticleCASPubMed Google Scholar
Pinschewer, D.D. et al. Kinetics of protective antibodies are determined by the viral surface antigen. J. Clin. Invest.114, 988–993 (2004). ArticleCASPubMedPubMed Central Google Scholar
Nicol, M. et al. Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: a randomized trial. Pediatr. Infect. Dis. J.21, 138–141 (2002). ArticlePubMed Google Scholar
Cassidy, W.M. et al. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics107, 626–631 (2001). ArticleCASPubMed Google Scholar
Ahman, H., Kayhty, H., Vuorela, A., Leroy, O. & Eskola, J. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. Vaccine17, 2726–2732 (1999). ArticleCASPubMed Google Scholar
Bosnak, M., Dikici, B., Bosnak, V. & Haspolat, K. Accelerated hepatitis B vaccination schedule in childhood. Pediatr. Int.44, 663–665 (2002). ArticlePubMed Google Scholar
Zinkernagel, R.M. et al. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev.156, 199–209 (1997). ArticleCASPubMed Google Scholar
Deloye, F., Doussau, F. & Poulain, B. Action mechanisms of botulinum neurotoxins and tetanus neurotoxins. C.R. Seances Soc. Biol. Fil.191, 433–450 (1997). CASPubMed Google Scholar
Turton, K., Chaddock, J.A. & Acharya, K.R. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem. Sci.27, 552–558 (2002). ArticleCASPubMed Google Scholar
Matsuda, M., Kamei, M., Sugimoto, N., Ma, Y. & Hashizume, S. Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies. Eur. J. Epidemiol.8, 1–8 (1992). ArticleCASPubMed Google Scholar
Gupta, R.K. & Siber, G.R. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay. Biologicals22, 215–219 (1994). ArticleCASPubMed Google Scholar
Siegrist, C.A. et al. Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. Vaccine23, 615–622 (2004). ArticleCASPubMed Google Scholar
Pihlgren, M. et al. CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice. Vaccine21, 2492–2499 (2003). ArticleCASPubMed Google Scholar
Usinger, W.R. & Lucas, A.H. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. Infect. Immun.67, 2366–2370 (1999). CASPubMedPubMed Central Google Scholar
Golaz, A. et al. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions. J. Infect. Dis.181 Suppl 1, S203–S207 (2000). ArticlePubMed Google Scholar
Banatvala, J., Van Damme, P. & Van Hattum, J. Boosters for hepatitis B. European Consensus Group on Hepatitis B Immunity. Lancet356, 337–338 (2000). ArticleCASPubMed Google Scholar
Goldblatt, D., Vaz, A.R. & Miller, E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J. Infect. Dis.177, 1112–1115 (1998). ArticleCASPubMed Google Scholar
Goldblatt, D., Miller, E., McCloskey, N. & Cartwright, K. Immunological response to conjugate vaccines in infants: follow up study. Br. Med. J.316, 1570–1571 (1998). ArticleCAS Google Scholar
McVernon, J., Johnson, P.D., Pollard, A.J., Slack, M.P. & Moxon, E.R. Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure. Arch. Dis. Child.88, 379–383 (2003). ArticleCASPubMedPubMed Central Google Scholar
Trotter, C.L., Andrews, N.J., Kaczmarski, E.B., Miller, E. & Ramsay, M.E. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet364, 365–367 (2004). ArticleCASPubMed Google Scholar
Davidkin, I., Peltola, H., Leinikki, P. & Valle, M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine18, 3106–3112 (2000). ArticleCASPubMed Google Scholar
Thomas, S.L. & Hall, A.J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis.4, 26–33 (2004). ArticlePubMed Google Scholar
Kaufmann, S.H.E. & McMichael, A. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med.11, Suppl 1, S33–S44 (2005). ArticleCASPubMedPubMed Central Google Scholar
Salmaso, S. et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics108, E81 (2001). ArticleCASPubMed Google Scholar
Giuliano, M. et al. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J. Pediatr.132, 983–988 (1998). ArticleCASPubMed Google Scholar
Gans, H.A. et al. IL-12, IFN-γ, and T cell proliferation to measles in immunized infants. J. Immunol.162, 5569–5575 (1999). CASPubMed Google Scholar
Alonso, P.L. et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet364, 1411–1420 (2004). ArticleCASPubMed Google Scholar
Ballou, W.R. et al. Update on the clinical development of candidate malaria vaccines. Am. J. Trop. Med. Hyg.71, 239–247 (2004). ArticlePubMed Google Scholar
Hoskins, T.W., Davies, J.R., Smith, A.J., Miller, C.L. & Allchin, A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet1, 33–35 (1979). ArticleCASPubMed Google Scholar
Powers, D.C. & Belshe, R.B. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and “original antigenic sin”. J. Infect. Dis.169, 1125–1129 (1994). ArticleCASPubMed Google Scholar
Smith, D.J., Forrest, S., Ackley, D.H. & Perelson, A.S. Variable efficacy of repeated annual influenza vaccination. Proc. Natl. Acad. Sci. USA96, 14001–14006 (1999). ArticleCASPubMedPubMed Central Google Scholar
Voordouw, A.C. et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. J. Am. Med. Assoc.292, 2089–2095 (2004). ArticleCAS Google Scholar
Robbins, F.C. The history of polio vaccine development. in Vaccines (eds. A., P.S. & Orenstein, W.A.) 17–30 (Elsevier, Philadelphia, 2004). Google Scholar
Bresee, J.S., Glass, R.I., Parashar, U. & Gentsch, J.G. Rotavirus. in The Vaccine Book (eds. Bloom, B.R. & Lambert, P.H.) 225–243 (Academic Press, Amsterdam, 2003). Chapter Google Scholar
Hackell, J.G. Pneumococcus, pneumococcal disease and prevention. in The Vaccine Book (eds. Bloom, B.R. & Lambert, P.H.) 257–277 (Academic Press, Amsterdam, 2003). Chapter Google Scholar
Hausdorff, W.P., Bryant, J., Paradiso, P.R. & Siber, G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis.30, 100–121 (2000). ArticleCASPubMed Google Scholar
Bosch, F.X. et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst.87, 796–802 (1995). ArticleCASPubMed Google Scholar
Kaplan, S.L. et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics113, 443–449 (2004). ArticlePubMed Google Scholar
Gans, H.A. et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. J. Am. Med. Assoc.280, 527–532 (1998). ArticleCAS Google Scholar
Vazquez, M. et al. Effectiveness over time of varicella vaccine. J. Am. Med. Assoc.291, 851–855 (2004). ArticleCAS Google Scholar
Pihlgren, M. et al. Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens. J. Immunol.170, 2824–2832 (2003). ArticleCASPubMed Google Scholar
Pihlgren, M. et al. Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. Eur. J. Immunol.31, 939–946 (2001). ArticleCASPubMed Google Scholar
Goriely, S. et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol.166, 2141–2146 (2001). ArticleCASPubMed Google Scholar
De Wit, D. et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood103, 1030–1032 (2004). ArticleCASPubMed Google Scholar
Goriely, S. et al. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J. Exp. Med.199, 1011–1016 (2004). ArticleCASPubMedPubMed Central Google Scholar
Ota, M.O. et al. Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine22, 511–519 (2004). ArticleCASPubMed Google Scholar
Marchant, A. et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J. Immunol.163, 2249–2255 (1999). CASPubMed Google Scholar
Ota, M.O. et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J. Immunol.168, 919–925 (2002). ArticleCASPubMed Google Scholar
Dagan, R. et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr. Infect. Dis. J.19, 1045–1052 (2000). ArticleCASPubMed Google Scholar
Shapiro, E.D. et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med.325, 1453–1460 (1991). ArticleCASPubMed Google Scholar
Bjorkholm, B., Hagberg, L., Sundbeck, G. & Granstrom, M. Booster effect of low doses of tetanus toxoid in elderly vaccinees. Eur. J. Clin. Microbiol. Infect. Dis.19, 195–199 (2000). ArticleCASPubMed Google Scholar
Gomez, I., Marx, F., Gould, E.A. & Grubeck-Loebenstein, B. T cells from elderly persons respond to neoantigenic stimulation with an unimpaired IL-2 production and an enhanced differentiation into effector cells. Exp. Gerontol.39, 597–605 (2004). ArticleCASPubMed Google Scholar
Powers, D.C. & Belshe, R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis.167, 584–592 (1993). ArticleCASPubMed Google Scholar
American Academy of Pediatrics. Tetanus. in Red Book 2003. Report of the Committee on Infectious Diseases 26th edn. (ed. Pickering, L.K.) 611–616 (American Academy of Pediatrics, Elk Grove Village, Illinois, USA, 2003).
Gupta, P.S., Kapoor, R., Goyal, S., Batra, V.K. & Jain, B.K. Intrathecal human tetanus immunoglobulin in early tetanus. Lancet2, 439–440 (1980). ArticleCASPubMed Google Scholar
American Academy of Pediatrics. Diphtheria. in Red Book 2003. Report of the Committee on Infectious Diseases 26th edn. (ed. Pickering, L.K.) 263–266 (American Academy of Pediatrics, Elk Grove Village, Illinois, USA, 2003).
Edwards, K.M. Pertussis: an important target for maternal immunization. Vaccine21, 3483–3486 (2003). ArticleCASPubMed Google Scholar
Siber, G.R. et al. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J. Infect. Dis.165 Suppl 1, S129–S133 (1992). ArticlePubMed Google Scholar
Gershon, A.A. Measles virus (rubeola). in Principles and Practice of Infectious Diseases 4th edn. (eds. Mandel, G.L., Bennett, J.E. & Dolin, R.) 1519–1528 (Churchill Livingstone, New York, 1995). Google Scholar
American Academy of Pediatrics. Measles. in Red Book 2003. Report of the Committee on Infectious Diseases 26th edn. (ed. Pickering, L.K.) 419–429 (American Academy of Pediatrics, Elk Grove Village, Illinois, USA, 2003).
Centers for Disease Control and Prevention. Human rabies prevention—United States, 1999. Recommendations of Advisory Committee (ACIP). MMWR Morbid. Mortal. Wkly. Rep.48, 1–21 (1999).
Hankins, D.G. & Rosekrans, J.A. Overview, prevention, and treatment of rabies. Mayo Clin. Proc.79, 671–676 (2004). ArticlePubMed Google Scholar
Kempe, C.H. et al. The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox. Bull. World Health Org.25, 41–48 (1961). CASPubMedPubMed Central Google Scholar
Galmiche, M.C., Goenaga, J., Wittek, R. & Rindisbacher, L. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology254, 71–80 (1999). ArticleCASPubMed Google Scholar
American Academy of Pediatrics. Hepatitis A. in Red Book 2003. Report of the Committee on Infectious Diseases 26th edn. (ed. Pickering, L.K.) 309–318 (American Academy of Pediatrics, Elk Grove Village, Illinois, USA, 2003).
Centers for Disease Control and Prevention. Postexposure prophylaxis of hepatitis B. MMWR Morbid. Mortal. Wkly. Rep.33, 398–402 (1984).
Terrault, N.A. et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology24, 1327–1333 (1996). ArticleCASPubMed Google Scholar
Storch, G.A. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Pediatrics102, 648–651 (1998). ArticleCASPubMed Google Scholar
Givner, L.B. Monoclonal antibodies against respiratory syncytial virus. Pediatr. Infect. Dis. J.18, 541–542 (1999). ArticleCASPubMed Google Scholar